留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

慢加急性肝衰竭的肝移植治疗

范祺, 李照. 慢加急性肝衰竭的肝移植治疗[J]. 器官移植, 2022, 13(3): 333-337. doi: 10.3969/j.issn.1674-7445.2022.03.008
引用本文: 范祺, 李照. 慢加急性肝衰竭的肝移植治疗[J]. 器官移植, 2022, 13(3): 333-337. doi: 10.3969/j.issn.1674-7445.2022.03.008
Fan Qi, Li Zhao. Liver transplantation for acute-on-chronic liver failure[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 333-337. doi: 10.3969/j.issn.1674-7445.2022.03.008
Citation: Fan Qi, Li Zhao. Liver transplantation for acute-on-chronic liver failure[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 333-337. doi: 10.3969/j.issn.1674-7445.2022.03.008

慢加急性肝衰竭的肝移植治疗

doi: 10.3969/j.issn.1674-7445.2022.03.008
基金项目: 

国家自然科学基金 81502509

详细信息
    作者简介:
    通讯作者:

    李照, Email: goodlizhao@sina.com

  • 中图分类号: R617, R575.3

Liver transplantation for acute-on-chronic liver failure

More Information
  • 摘要: 慢加急性肝衰竭(ACLF)是肝衰竭的一种特殊类型,以进展迅速、常伴有全身多个器官衰竭为主要特点。目前对于ACLF患者主要采用系统综合的内科支持治疗,促进肝脏再生。而对于内科治疗无效,迅速进展至多器官衰竭者,肝移植是唯一有潜在治愈可能的治疗方式。但考虑到不同患者的病情进程、预后转归的差异以及我国供肝的紧缺性,积极预防慢性肝病患者ACLF的触发因素,筛选出最可能获益的肝移植受者以及肝移植围手术期的精细管理显得尤为重要。本文拟从ACLF的精确评估、肝移植手术指征的精准把握及围手术期的精细管理等方面探讨肝移植在ACLF中的应用,以优化ACLF肝移植的治疗策略。

     

  • [1] HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: an update[J]. Gut, 2017, 66(3): 541-553. DOI: 10.1136/gutjnl-2016-312670.
    [2] KHANAM A, KOTTILIL S. Acute-on-chronic liver failure: pathophysiological mechanisms and management[J]. Front Med (Lausanne), 2021, 8: 752875. DOI: 10.3389/fmed.2021.752875.
    [3] 孙梦滢, 陈备金, 李浩, 等. 晚期乙型肝炎相关慢加急性肝衰竭患者预后相关因素分析[J]. 中华肝脏病杂志, 2021, 29(10): 983-986. DOI: 10.3760/cma.j.cn501113-20200630-00354.

    SUN MY, CHEN BJ, LI H, et al. Analysis of prognosis-related factors in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Hepatol, 2021, 29(10): 983-986. DOI: 10.3760/cma.j.cn501113-20200630-00354.
    [4] JALAN R, GUSTOT T, FERNANDEZ J, et al. 'Equity' and 'Justice' for patients with acute-on chronic liver failure: a call to action[J]. J Hepatol, 2021, 75(5): 1228-1235. DOI: 10.1016/j.jhep.2021.06.017.
    [5] ABDALLAH MA, KUO YF, ASRANI S, et al. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality[J]. J Hepatol, 2021, 74(6): 1355-1361. DOI: 10.1016/j.jhep.2020.12.003.
    [6] 李郑红, 董育玮, 陆伦根. 肝肾综合征发生的危险因素、诊断和最新分型[J]. 临床肝胆病杂志, 2020, 36(11): 2411-2414. DOI: 10.3969/j.issn.1001-5256.2020.11.003.

    LI ZH, DONG YW, LU LG. Risk factors, diagnosis, and updated classification of hepatorenal syndrome[J]. J Clin Hepatol, 2020, 36(11): 2411-2414. DOI: 10.3969/j.issn.1001-5256.2020.11.003.
    [7] BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. DOI: 10.1053/j.gastro.2006.02.010.
    [8] 韩成美, 任运华, 丁雷. COSSH-ACLF评分联合血清白细胞介素-37水平对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值[J]. 实用医学杂志, 2021, 37(4): 472-476. DOI: 10.3969/j.issn.1006-5725.2021.04.011.

    HAN CM, REN YH, DING L. The evaluation value of COSSH-ACLF score combined with serum IL-37 level in short-term prognosis of patients with chronic hepatitis B Virus (HBV) associated with acute liver failure[J]. J Pract Med, 2021, 37(4): 472-476. DOI: 10.3969/j.issn.1006-5725.2021.04.011.
    [9] ZHENG MH, SHI KQ, FAN YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9(4): 351-356. DOI: 10.1016/j.cgh.2010.12.027.
    [10] XIA Q, DAI X, ZHANG Y, et al. A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients[J]. PLoS One, 2013, 8(6): e64379. DOI: 10.1371/journal.pone.0064379.
    [11] ARTZNER T, MICHARD B, WEISS E, et al. Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors[J]. Am J Transplant, 2020, 20(9): 2437-2448. DOI: 10.1111/ajt.15852.
    [12] BURRA P, SAMUEL D, SUNDARAM V, et al. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation[J]. J Hepatol, 2021, 75 (Suppl 1): S178-S190. DOI: 10.1016/j.jhep.2021.01.007.
    [13] LINECKER M, KRONES T, BERG T, et al. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - a search for the upper limits[J]. J Hepatol, 2018, 68(4): 798-813. DOI: 10.1016/j.jhep.2017.11.008.
    [14] LEVESQUE E, WINTER A, NOORAH Z, et al. Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation[J]. Liver Int, 2017, 37(5): 684-693. DOI: 10.1111/liv.13355.
    [15] ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67(4): 708-715. DOI: 10.1016/j.jhep.2017.06.009.
    [16] THULUVATH PJ, THULUVATH AJ, SAVVA Y, et al. Karnofsky performance status following liver transplantation in patients with multiple organ failures and probable acute-on-chronic liver failure[J]. Clin Gastroenterol Hepatol, 2020, 18(1): 234-241. DOI: 10.1016/j.cgh.2019.03.016.
    [17] WEISS E, SANER F, ASRANI SK, et al. When is a critically ill cirrhotic patient too sick to transplant? development of consensus criteria by a multidisciplinary panel of 35 international experts[J]. Transplantation, 2021, 105(3): 561-568. DOI: 10.1097/TP.0000000000003364.
    [18] ABDALLAH MA, WALEED M, BELL MG, et al. Systematic review with Meta-analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure[J]. Aliment Pharmacol Ther, 2020, 52(2): 222-232. DOI: 10.1111/apt.15793.
    [19] ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2020, 3(1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
    [20] SU H, TONG J, LIU X, et al. Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure[J]. Eur J Gastroenterol Hepatol, 2021, 33(1): 83-88. DOI: 10.1097/MEG.0000000000001699.
    [21] ALSHAMSI F, ALSHAMMARI K, BELLEY-COTE E, et al. Extracorporeal liver support in patients with liver failure: a systematic review and Meta-analysis of randomized trials[J]. Intensive Care Med, 2020, 46(1): 1-16. DOI: 10.1007/s00134-019-05783-y.
    [22] CHANCHAROENTHANA W, LEELAHAVANICHKUL A. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?[J]. World J Gastroenterol, 2019, 25(28): 3684-3703. DOI: 10.3748/wjg.v25.i28.3684.
    [23] KARVELLAS CJ, TAYLOR S, BIGAM D, et al. Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION)[J]. Can J Anaesth, 2019, 66(10): 1151-1161. DOI: 10.1007/s12630-019-01454-0.
    [24] 中华医学会器官移植学分会围手术期管理学组. 肝衰竭肝移植围手术期管理中国专家共识(2021版)[J]. 中华消化外科杂志, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.

    Perioperative Management Group of Organ Transplantation Branch of Chinese Medical Association. Chinese expert consensus on perioperative management of liver transplantation in patients with liver failure (2021 edition)[J]. Chin J Dig Surg, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.
    [25] 吴若林, 赵红川, 耿小平. 肝移植治疗成人慢加急性肝功能衰竭的现状[J]. 中华外科杂志, 2022, 60(2): 182-188. DOI: 10.3760/cma.j.cn112139-20210810-00369.

    WU RL, ZHAO HC, GENG XP. Current status of liver transplantation for adult patients with acute-on-chronic liver failure[J]. Chin J Surg, 2022, 60(2): 182-188. DOI: 10.3760/cma.j.cn112139-20210810-00369.
    [26] TEEGEN EM, MAURER MM, GLOBKE B, et al. Liver transplantation for Hepatitis-B-associated liver disease - three decades of experience[J]. Transpl Infect Dis, 2019, 21(1): e12997. DOI: 10.1111/tid.12997.
    [27] BHATTI ABH, DAR FS, BUTT MO, et al. Living donor liver transplantation for acute on chronic liver failure based on EASL-CLIF diagnostic criteria[J]. J Clin Exp Hepatol, 2018, 8(2): 136-143. DOI: 10.1016/j.jceh.2017.11.007.
    [28] GOUSSOUS N, XIE W, ZHANG T, et al. Acute on chronic liver failure: resource utilization and predictors for liver transplantation[J]. Am J Transplant, 2021, 21(S1): 36.
    [29] MACCONMARA M, HANISH SI, HWANG CS, et al. Making every liver count: increased transplant yield of donor livers through normothermic machine perfusion[J]. Ann Surg, 2020, 272(3): 397-401. DOI: 10.1097/SLA.0000000000004198.
    [30] ENGELMANN C, HERBER A, FRANKE A, et al. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)[J]. J Hepatol, 2021, 75(6): 1346-1354. DOI: 10.1016/j.jhep.2021.07.033.
    [31] ZHU B, YOU S, RONG Y, et al. A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure[J]. Braz J Med Biol Res, 2020, 53(11): e9728. DOI: 10.1590/1414-431X20209728.
    [32] ALHOMRANI M, CORREIA J, ZAVOU M, et al. The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis[J]. Front Pharmacol, 2017, 8: 748. DOI: 10.3389/fphar.2017.00748.
  • 加载中
图(1)
计量
  • 文章访问数:  342
  • HTML全文浏览量:  175
  • PDF下载量:  109
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-02-13
  • 网络出版日期:  2022-04-29
  • 刊出日期:  2022-05-15

目录

    /

    返回文章
    返回